PlainRecalls
FDA Drug Critical Class I Terminated

Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10

Reported: February 16, 2022 Initiated: January 26, 2022 #D-0556-2022

Product Description

Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10

Reason for Recall

Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot

Details

Recalling Firm
AuroMedics Pharma LLC
Units Affected
35,520 vials
Distribution
Nationwide in the US
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10. Recalled by AuroMedics Pharma LLC. Units affected: 35,520 vials.
Why was this product recalled?
Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot
Which agency issued this recall?
This recall was issued by the FDA Drug on February 16, 2022. Severity: Critical. Recall number: D-0556-2022.